FDA Decision To Revoke Avastin For Breast Cancer Use Remains Topic Of Debate

[News]

Physicians, lawmakers and advocates continue to debate FDA's decision last month to revoke approval of Genentech's drug Avastin for breast cancer treatment, USA Today reports...

More... (http://mnt.to/f/3PHv)